PSMA6 and Hypertension: Almost all patients (92%) were treated for arterial hypertension, with calcium channel blockers (CCBs) and beta blockers as the most commonly used agents, followed by centrally acting antihypertensives, RAAS inhibitors, and alpha-1 antagonists.